New publication on the benefits of our hydrogel EHO-85 containing olive leaves extract in accelerating early wound healing.
A sub-analysis of previous clinical trial (1) conducted with the EHO-85 hydrogel in the treatment of patients with pressure ulcers, venous ulcers or diabetic foot
New publication on Recurrent UTI: Q&A on Clinical Practice1
A novel mode of action to promote antibiotic-sparing approach to Recurrent UTIs: Questions and Answers on Clinical Practice1 Consultations for recurrent urinary tract infections (rUTIs)
New publication on the mode of action of Mucoprotectants: gelatin tannate and xyloglucan show similar effectivity on preventing Cholera Toxin-Induced diarrhea in experimental studies1
The newer antidiarrheal agents include the mucoprotectants gelatin tannate and xyloglucan. Both were able to attenuate cholera toxin-induced intra-loop water secretion in an experimental study
New publication for Utipro® Plus / Utipro® Plus AF
Let’s celebrate 2022 with a new paper on Utipro® Plus and Utipro® Plus AF!! We are pleased to announce the publication of a meta-analysis in
Do you know Noventure?
You may know that Noventure is a Spanish company from Barcelona, part of Ferrer, specialized in medical devices & innovative food supplements. But… who are
Second publication for OLE hydrogel
After the publication of the first paper in which the significant antioxidant activity of Olea europaea leaf extract (OELE) was observed and assessed, we are happy to
Publication of first clinical evidence for EHO-85 hydrogel
The first clinical evidence related to an hydrogel based on Olea europaea leaf extract (EHO‐85) indicated for the healing of wounds of full and partial thickness has been published in the Journal
Impact of Covid-19 on UTI and antibiotic stewardship (T. Cai et al. on Uro 2022)
Several recent studies showed that, despite the overall percentage of bacterial co-infection among COVID-19 patients was low, the use of antibiotic was high. This motivated
First publication for OLE hydrogel
We are happy to announce the publication in Pharmaceutics of the first paper related to our hydrogel based on Olea europaea leaf extract (OELE) indicated for the healing of wounds of full and partial
Press Release: Noventure acquires Ulkox® and Oleoabrax®, two medical devices based on patented new wound-healing technology
Acquisition allows Noventure to maintain focus on medical devices and grow therapeutic areas in which it operates Medical devices contain Olea Europaea leaf extract, showing
